Yoshio Sumida

Associate professor

Aichi Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yoshio Sumida is an Associate Professor at Aichi Medical University in Japan. His research areas include metabolic dysfunction-associated steatotic liver disease, nonalcoholic fatty liver disease, and advanced fibrosis diagnostics. He has contributed to numerous articles examining methods for liver disease prediction and characterization of patient health outcomes.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Makoto Fujii

Associate Professor (full-time)

Osaka University

JAPAN

View details

Eiichi Tomita

JAPAN

View details

Yoshihiro Kamada

Osaka University

JAPAN

View details

Takumi Kawaguchi

Kurume University School of Medicine

JAPAN

View details

Asahiro Morishita

Assistant Professor

Kagawa University Faculty of Medicine

JAPAN

View details

Hidenao Noritake

Hamamatsu University School of Medicine

JAPAN

View details

Hiroshi Tobita

Shimane University Hospital

JAPAN

View details

Atsushi Nakajima

Yokohama National University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshio Sumida

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L

Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction–associated steatotic liver disease

Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease

Noninvasive tests predict liver‐related events and mortality in patients with nonalcoholic fatty liver disease: sub‐analysis of the CLIONE‐Asia study

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients

An examination of eating behavior in patients with non-alcoholic fatty liver disease: A cross-sectional study in a Japanese population

Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma

Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

Role of vitamin E in the treatment of non-alcoholic steatohepatitis

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis

Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan

Collaborators (8)

Makoto Fujii

Eiichi Tomita

Yoshihiro Kamada

Takumi Kawaguchi

Asahiro Morishita

Hidenao Noritake

Hiroshi Tobita

Atsushi Nakajima

Make your next move.